| Neuland Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524558 |
NSE Symbol : NEULANDLAB |
P/E(TTM) : 71.11 |
|
ISIN Demat : INE794A01010 |
Div & Yield% : 0.17 |
EPS(TTM) : 280.77 |
|
Book Value(₹) : 1,453.59 |
Market Cap(₹Cr) : 25,614.49 |
Face Value(₹) : 10.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,022.99 | 1,476.84 | 1,558.58 | 1,191.20 | 951.08 |
| Other Income | 30.16 | 96.91 | 12.54 | 9.75 | 2.08 |
| Stock Adjustments | 64.26 | -12.83 | 55.14 | 9.51 | 15.41 |
| Total Income | 2,117.41 | 1,560.92 | 1,626.26 | 1,210.46 | 968.57 |
| EXPENDITURE : | |||||
| Raw Materials | 823.89 | 578.45 | 636.49 | 491.98 | 441.79 |
| Power and Fuel Cost | 58.14 | 50.56 | 48.72 | 48.62 | 42.21 |
| Other Manufacturing Expenses | 129.35 | 108.66 | 103.73 | 82.69 | 84.92 |
| Selling and Administration Expenses | 154.17 | 120.52 | 104.29 | 88.50 | 70.50 |
| Miscellaneous Expenses | 19.63 | 22.11 | 10.04 | 22.77 | 9.12 |
| Employee Benefit Expenses | 328.82 | 261.40 | 248.53 | 194.84 | 175.76 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 603.41 | 419.22 | 474.47 | 281.06 | 144.27 |
| Interest | 23.95 | 8.30 | 14.00 | 13.07 | 13.49 |
| Gross Profit | 579.46 | 410.92 | 460.47 | 267.99 | 130.78 |
| Depreciation | 91.73 | 65.54 | 59.70 | 52.78 | 49.04 |
| Profit Before Tax | 487.73 | 345.38 | 400.77 | 215.21 | 81.74 |
| Current Tax | 128.88 | 73.65 | 99.59 | 50.39 | 20.42 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -4.26 | 12.29 | 1.59 | 1.70 | -2.22 |
| Reported Net Profit | 363.11 | 259.43 | 299.60 | 163.12 | 63.53 |
| Extraordinary Items | 2.88 | 86.29 | -0.30 | -0.66 | -1.36 |
| Adjusted Net Profit | 360.23 | 173.14 | 299.90 | 163.78 | 64.89 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 988.77 | 747.31 | 460.54 | 303.84 | 244.15 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 15.40 | 17.96 | 12.83 | 6.41 | 3.85 |
| P & L Balance carried down | 1,336.48 | 988.77 | 747.31 | 460.54 | 303.84 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 340.00 | 120.00 | 140.00 | 100.00 | 50.00 |
| Dividend Per Share(Rs) | 34.00 | 12.00 | 14.00 | 10.00 | 5.00 |
| Earnings Per Share-Unit Curr | 281.47 | 201.10 | 232.24 | 126.44 | 49.25 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 1,445.69 | 1,175.89 | 988.88 | 765.49 | 647.06 |
| Book Value(Adj)-Unit Curr | 1,445.69 | 1,175.89 | 988.88 | 765.49 | 647.06 |
